Table of Contents
THE ARTIFICIAL CELL Introduction to artificial cells: concept, history, design, current status and future S Prakash, J R Bhathena and H Chen, McGill University, Canada Polymeric hydrophilic polymers in targeted drug delivery K Poon, V Castellino and Y-L Cheng, University of Toronto, Canada The artificial cell design: liposomes G Barratt, Centre d'Etudes Pharmaceutiques, France The artificial cell design: nanoparticles W Yu and S Su, Celsion Corporation, USA CELL ENGINEERING The cutting edge: apoptosis and therapeutic opportunity C Griffin, D Gueorguieva, A McLachlan-Burgess, M Somayajulu-Nitu and S Pandey, University of Windsor, Canada Bone marrow stromal cells in myocardial regeneration and the role of cell signalling R Atoui, R C J Chiu and D Shm-Tim, McGill University, Canada Musculoskeletal tissue engineering with skeletal muscle-derived stem cells K A Corsi and J Huard, University of Pittsburgh, USA ARTIFICIAL CELLS FOR CELL THERAPY Artificial cell for oral delivery of live bacterial cells for therapy S Prakash, J Bhathena and A M Uurbanska, McGill University, Canada Artificial cells in liver disease V Dixit, University of California, USA Artificial cells as a novel approach to gene therapy M Potter, A Li, P Cirone, F Shen and P Chang, McMaster University, Canada Capillary devices for therapy J W Kawiak, L H Granicka, A Werynski and J M Wójcicki, Institute of Biocybernetics and Biomedical Engineering PAS and Medical Centre of Postgraduate Education, Poland THE CLINICAL RELEVANCE OF ARTIFICIAL CELLS AND CELL ENGINEERING Artificial cells in medicine: with emphasis on blood substitutes T M W Chang, McGill University, Canada Bone marrow stromal cells as 'universal donor cells' for myocardial regeneration therapy J Luo, R C-J Chiu and D Shum-Tim, McGill University, Canada Myocardial regeneration, tissue engineering and therapy R L kao, C E Ganote, D G Pennington and I W Browder, East Tennessee State University, USA Kidney diseases and potentials of artificial cells S Prakash, T Lim and W Ouyang, McGill University, Canada Engineered cells for treatment of diabetes S Efrat, Tel Aviv University, Israel Drug delivery system for active brain targeting X-G Mei, Beijing Institute of Pharmacology and Toxicology, China Artificial cells in enzyme therapy with emphasis on tyrosinase for melanoma in mice B Yu and T M S Chang, McGill University, Canada Stem cell and regenerative medicine: commercial and pharmaceutical implications L E Cruz and S P Azevedo, Cryopraxis Criobiologia Ltd, Brazil Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present therapy and therapeutic potential of cell-based therapy S-P Luh and S-Y Jiang, Tzu-Chi Medical University Hospital and R-Y Shyu, National Defence Medical Centre, Taiwan Inflammatory bowel diseases: current treatment strategies and potential for drug delivery using artificial cell microcapsules D Amre, University of Montreal, Canada and P D Amre and S Prakash, McGill University, Canada Carrier-mediated and artificial-cell targeted cancer drug delivery W C Zamboni, University of Pittsburgh, USA
